Trial Information
(UTX-TGR-204) A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination with Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
